๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Active Ulcerative Colitis

Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis NCT06453317Phase 21 site๐Ÿ“ Lodz Medical University of Lodz ยท Tests: Infliximab, Ustekinumab Leucine-rich ฮฑ2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context NCT07621783n/a1 site๐Ÿ“ Bonheiden Imelda GI Clinical Research Center ยท Tests: Leucine-rich ฮฑ2-glycoprotein A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis NCT07470879Phase 246 sites๐Ÿ“ Indianapolis๐Ÿ“ Indianapolis๐Ÿ“ Indianapolis Pfizer ยท Tests: Etrasimod Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis NCT07136116n/a29 sites๐Ÿ“ Nagakute๐Ÿ“ Nagoya๐Ÿ“ Hirosaki AbbVie Palmitoylethanolamide in Ulcerative Colitis NCT07609810NA1 site๐Ÿ“ Cairo Ain Shams University ยท Tests: Palmitoylethanolamide (PEA), Placebo Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies NCT07427017Phase 21 site๐Ÿ“ Chicago Northwestern University ยท Tests: Selenium supplementation, Placebo A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea NCT06073873n/a1 site๐Ÿ“ Seoul Bristol-Myers Squibb ยท Tests: Ozanimod Diet Intervention Treatment for Active Ulcerative Colitis NCT04121806NA1 site๐Ÿ“ Toronto Mount Sinai Hospital, Canada ยท Tests: UC intervention diet A Study to Assess the Efficacy and Safety of Subcutaneous Induction Therapy With Afimkibart in Participants With Moderately to Severely Active Ulcerative Colitis NCT07846683Phase 31 site๐Ÿ“ Cordova Hoffmann-La Roche ยท Tests: Afimkibart, Placebo Superdonor FMT in Patients With Ulcerative Colitis NCT05739864Phase 1, Phase 21 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: FMT, Placebo FMT Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD) NCT07191106NA2 sites๐Ÿ“ Montfermeil๐Ÿ“ Nantes Raincy Montfermeil Hospital Group ยท Tests: adapted physical activity A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) NCT06764615Phase 216 sites๐Ÿ“ Glen Burnie๐Ÿ“ Tyler๐Ÿ“ Chongqing Takeda ยท Tests: Zasocitinib A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002) NCT07463183Phase 239 sites๐Ÿ“ Anaheim๐Ÿ“ Coronado๐Ÿ“ Colorado Springs Merck Sharp & Dohme LLC ยท Tests: MK-8690, Placebo A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease NCT07113522Phase 266 sites๐Ÿ“ Birmingham๐Ÿ“ Scottsdale๐Ÿ“ Sun City Mirador Therapeutics, Inc. ยท Tests: MT-501, MT-201 A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis NCT07374471Phase 1, Phase 27 sites๐Ÿ“ Tbilisi๐Ÿ“ Chisinau๐Ÿ“ Katowice Mage Biologics ยท Tests: MB-001, Matching placebo to MB-001 The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC NCT07507513Phase 21 site๐Ÿ“ Guangzhou Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. ยท Tests: 627, Placebo Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD) NCT07245394n/a14 sites๐Ÿ“ Calgary๐Ÿ“ Fredericton๐Ÿ“ Hamilton TIDHI Innovation Inc. ยท Tests: Guselkumab (Tremfya) A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis NCT05287126Phase 247 sites๐Ÿ“ Little Rock๐Ÿ“ Little Rock๐Ÿ“ Garden Grove Pfizer ยท Tests: Etrasimod Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases NCT06742385NA1 site๐Ÿ“ Neuilly-sur-Seine Groupe d'Etude Therapeutique des Affections Inflammatoires โ€ฆ ยท Tests: MedicWise A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting NCT06581328Phase 4101 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Chandler Takeda ยท Tests: Vedolizumab IV, Vedolizumab SC Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis NCT04314375Phase 44 sites๐Ÿ“ Garden Grove๐Ÿ“ Indianapolis๐Ÿ“ The Bronx Bausch Health Americas, Inc. ยท Tests: Low Dose Budesonide, High Dose Budesonide, Placebo A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis NCT07692165Phase 1, Phase 215 sites๐Ÿ“ Guangzhou๐Ÿ“ Shenyang๐Ÿ“ Beijing Innatus Therapeutics (Shanghai) Co., Ltd. ยท Tests: INT-210 Capsule, INT-210 Capsule Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis NCT06764706n/a57 sites๐Ÿ“ Heidelberg๐Ÿ“ Potsdam๐Ÿ“ Wriezen AbbVie A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis NCT06865417Phase 346 sites๐Ÿ“ Brussels๐Ÿ“ Liรจge๐Ÿ“ Namur Alfasigma S.p.A. ยท Tests: Filgotinib An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis NCT07665723Phase 118 sites๐Ÿ“ Chula Vista๐Ÿ“ Miami๐Ÿ“ Miami Hoffmann-La Roche ยท Tests: Afimkibart, Caffeine, Warfarin, Omeprazole, Dextromethorphan Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis NCT07697456Phase 266 sites๐Ÿ“ Dothan๐Ÿ“ Phoenix๐Ÿ“ Sun City AbbVie ยท Tests: Risankizumab, Trosunilimab, ABBV-701 Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome) NCT02421705NA1 site๐Ÿ“ Leuven KU Leuven ยท Tests: Sample collection A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis NCT07196748Phase 3402 sites๐Ÿ“ Chandler๐Ÿ“ Litchfield Park๐Ÿ“ Scottsdale Janssen Research & Development, LLC ยท Tests: Icotrokinra, Placebo Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis. NCT07389824NA1 site๐Ÿ“ Wuhan Qin Yu ยท Tests: Acupuncture, Sham acupuncture, Mesalazine Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis NCT07686081Phase 32 sites๐Ÿ“ Chula Vista๐Ÿ“ Nashville Vanda Pharmaceuticals ยท Tests: Ponesimod, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy